FR2469181A1 - Composition pharmaceutique contenant du phthalazinol - Google Patents

Composition pharmaceutique contenant du phthalazinol

Info

Publication number
FR2469181A1
FR2469181A1 FR8023577A FR8023577A FR2469181A1 FR 2469181 A1 FR2469181 A1 FR 2469181A1 FR 8023577 A FR8023577 A FR 8023577A FR 8023577 A FR8023577 A FR 8023577A FR 2469181 A1 FR2469181 A1 FR 2469181A1
Authority
FR
France
Prior art keywords
pharmaceutical composition
phthalazinol
composition containing
pharmaceutical
phtalazone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8023577A
Other languages
English (en)
French (fr)
Other versions
FR2469181B1 (enExample
Inventor
Hiroshi Miyazaki
Taka Aki Ohkuma
Yukiko Minatogawa
Hiroshi Ninomiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of FR2469181A1 publication Critical patent/FR2469181A1/fr
Application granted granted Critical
Publication of FR2469181B1 publication Critical patent/FR2469181B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8023577A 1979-11-07 1980-11-05 Composition pharmaceutique contenant du phthalazinol Granted FR2469181A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14339679A JPS5668609A (en) 1979-11-07 1979-11-07 Phthalazinol preparation

Publications (2)

Publication Number Publication Date
FR2469181A1 true FR2469181A1 (fr) 1981-05-22
FR2469181B1 FR2469181B1 (enExample) 1984-01-06

Family

ID=15337783

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8023577A Granted FR2469181A1 (fr) 1979-11-07 1980-11-05 Composition pharmaceutique contenant du phthalazinol

Country Status (7)

Country Link
US (1) US4406879A (enExample)
JP (1) JPS5668609A (enExample)
CA (1) CA1159766A (enExample)
DE (1) DE3041526A1 (enExample)
FR (1) FR2469181A1 (enExample)
GB (1) GB2062462B (enExample)
IT (1) IT8025835A0 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492034A1 (de) 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
US3840662A (en) * 1971-08-05 1974-10-08 Shimamoto Takio Method of treating atherosclerosis using 4-hydroxymethyl-1-keto-1,2-dihydrophthalazine or acid salts thereof
ZA739543B (en) 1973-02-16 1975-03-26 Hoffmann La Roche Free-flowing, directly tablettable, pharmaceutically active substances
AR205004A1 (es) * 1973-10-30 1976-03-31 Ishikawa M Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
GB1579818A (en) 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity

Also Published As

Publication number Publication date
US4406879A (en) 1983-09-27
CA1159766A (en) 1984-01-03
JPS5668609A (en) 1981-06-09
GB2062462A (en) 1981-05-28
IT8025835A0 (it) 1980-11-07
DE3041526A1 (de) 1981-05-21
GB2062462B (en) 1983-08-24
FR2469181B1 (enExample) 1984-01-06

Similar Documents

Publication Publication Date Title
ATE241365T1 (de) Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
TNSN97091A1 (fr) CONJUGUE PEG-IFN α PHYSIOLOGIQUEMENT ACTIF, PROCEDE POUR SA PREPARATION, COMPOSITIONS PHARMACEUTIQUES LE CONTENANT ET LEUR UTILISATION
FR2411821A1 (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et 1-hydroxyoctahydrophenanthrene-9-ones et medicament les contenant
ATE4168T1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
FR2358155A1 (fr) Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
TNSN98024A1 (fr) 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2407926A1 (fr) Derives de quinazoline, leur procede de production et composition pharmaceutique les contenant
FR2453650A1 (fr) Medicament a base de derives du cholecalciferol, utilisable pour regler le metabolisme des os chez les homeothermes
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
TNSN00139A1 (fr) Acides phenoxyacetiques substitues
FR2510889B1 (fr) Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau
GOLDEN Livedo reticularis in systemic lupus erythematosus
FR2469181A1 (fr) Composition pharmaceutique contenant du phthalazinol
EP0138720A3 (fr) Nouveaux benzenesulfonamides n-cyclises, leur procédé de préparation et leur utilisation comme substance active de compositions pharmaceutiques
BE900012A (fr) Nouveau peptide.
FR2619713B1 (fr) Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
DE3784628D1 (de) Dermale behandlung von wurmerkrankungen der katze mit praziquantel.
FR2614203B1 (fr) Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation.
BE884577A (fr) Solution aqueuse d'extraits de tissus animaux et traitement electro-chimique en vue de l'accroissement des processus metabolique des epitheliums
DE59006307D1 (de) Badezusatz und dessen Verwendung.
BE771357A (fr) Composition pour le traitement bactericide de zones isolees de la peau de l'homme et pour le traitement d'affections cutanees.
BE902055A (fr) Preparations pharmaceutiques.
FR2399249A1 (fr) Compositions ophtalmiques contenant de l'acide 1,3-dioxo-1h-benz(d,e)isoquinoline-2(3h)-acetique

Legal Events

Date Code Title Description
ST Notification of lapse